Plant with altered content of steroidal glycoalkaloids

1. A genetically modified plant comprising at least one cell having altered expression of at least one gene selected from the group consisting of a gene encoding GAME9-transcription factor and a gene encoding 2-oxoglutarate-dependent dioxygenase (GAME11), or a combination thereof, wherein the altered expression of the at least one gene or any combination thereof is elevated compared to its expression in the corresponding unmodified plant, wherein the amino acid sequence of the GAME9-transcription factor comprises the sequence set forth in SEQ ID NO:1 or the sequence at least 80% homologous to the sequence set forth in SEQ ID NO: 1, and wherein the amino acid sequence of the 2-oxoglutarate-dependent dioxygenase (GAME11) comprises the sequence set forth in any one of SEQ ID NO:7 and SEQ ID NO:8, wherein the genetically modified plant has an elevated content of at least one steroidal alkaloid or a glycosylated derivative thereof compared to a corresponding unmodified plant.

2. The genetically modified plant of claim 1 , wherein the GAME9-transcription factor comprises the amino acid sequence set forth in any one of SEQ ID NO:1 and SEQ ID NO:2.

3. The genetically modified plant of claim 1 , wherein the gene encoding the GAME9-transcription factor comprises the nucleic acid sequence set forth in any one of SEQ ID NO:4, and SEQ ID NO:6.

4. The genetically modified plant of claim 1 , wherein the gene encoding the GAME11 dioxygenase comprises the nucleic acid sequence set forth in any one of SEQ ID NO:9, SEQ ID NO:10, SEQ ID NO:11 and SEQ ID NO:12.

5. The genetically modified plant of claim 1 , wherein said plant comprises at least one cell having elevated expression of the gene encoding the GAME9-transcription factor, and the gene encoding the GAME11 dioxygenase compared to the corresponding unmodified plant.

6. The genetically modified plant of claim 1 , wherein said plant is a Solanaceous crop plant.

7. A genetically modified plant comprising at least one cell having altered expression of at least one gene selected from the group consisting of a gene encoding GAME9-transcription factor and a gene encoding 2-oxogluterate-dependent dioxygenase (GAME11), or a combination thereof, wherein the said altered expression of the at least one gene or any combination thereof is inhibited expression compared to its expression in the corresponding unmodified plant, wherein the amino acid sequence of the GAME9-transcription factor comprises the sequence set forth in SEQ ID NO:1 or the sequence at least 80% homologous to the sequence set forth in SEQ ID NO: 1, and wherein the amino acid sequence of the 2-oxoglutarate-dependent dioxygenase (GAME11) comprises the sequence set forth in any one of SEQ ID NO:7 and SEQ ID NO:8, wherein said genetically modified plant comprises reduced content of at least one steroidal alkaloid or a glycosylated derivative thereof compared to said corresponding unmodified plant.

8. The genetically modified plant of claim 7 , wherein said plant is a transgenic plant comprising at least one cell comprising at least one silencing molecule targeted to a gene selected from the group consisting of GAME9, or GAME11, or a combination thereof.

9. The genetically modified plant of claim 8 , wherein the silencing molecule is selected from the group consisting of an RNA interference molecule and an antisense molecule, or wherein said silencing molecule is a component of a viral induced gene silencing system.

10. The genetically modified plant of claim 8 , wherein the silencing molecule comprises a polynucleotide comprising nucleic acid sequence complementary to a region of the GAME9 gene or the complementary sequence thereof, wherein the nucleic acid sequence of the GAME9 gene is set forth in any one of SEQ ID NO:4 and SEQ ID NO:6.

11. The genetically modified plant of claim 10 , wherein the silencing molecule is targeted to a GAME9 fragment comprising the nucleic acid sequence set forth in SEQ ID NO: 18 or the complementary sequence thereof.

12. The genetically modified plant of claim 8 , wherein the silencing molecule comprises a polynucleotide having nucleic acid sequence complementary to a region of the GAME11 gene or the complementary sequence thereof, wherein the nucleic acid sequence of the GAME11 gene is set forth in any one of SEQ ID NO: 10 and SEQ ID NO:12.

13. The genetically modified plant of claim 12 , wherein the silencing molecule is targeted to a GAME11 fragment comprising the nucleic acid sequence set forth in SEQ ID NO:19 or the complementary sequence thereof.

14. The genetically modified plant of claim 8 , wherein said transgenic plant is a Solanaceous crop plant having reduced content of at least one steroidal glycoalkaloid selected from the group comprising α-solanine, α-chaconine, solmargine, solasonine, tomatine, tomatidine and derivatives thereof.

15. The genetically modified plant of claim 14 , wherein said transgenic plant further comprises an elevated amount of at least one of steroidal saponin.

16. The genetically modified plant of claim 14 , wherein said transgenic plant is a potato or an eggplant plant comprising a reduced content of at least α-solanine, α-chaconine, solmargine, and solasonine compared to a corresponding non-transgenic plant.

17. The genetically modified plant of claim 14 , wherein said transgenic plant is a tomato plant comprising a reduced content of tomatine, tomatidine or derivatives thereof compared to a corresponding non-transgenic plant.

18. The genetically modified plant of claim 17 , wherein said transgenic plant further comprises an elevated amount of at least one of cholestanol-type saponins.

19. The genetically modified plant of claim 1 , wherein said genetically modified plant is a transgenic plant comprising at least one cell comprising at least one transcribable polynucleotide encoding at least one protein selected from the group consisting of the GAME9-transcription factor, or the 2-oxoglutarate-dependent dioxygenase (GAME11), or a combination thereof.

20. The genetically modified plant of claim 19 , wherein said transgenic plant comprises a transcribable polynucleotide encoding the GAME9-transcription factor.

21. The genetically modified plant of claim 20 , wherein the transcribable polynucleotide comprises the nucleic acid sequence set forth in any one of SEQ ID NO:4 and SEQ ID NO:6.

22. The genetically modified plant of claim 19 , wherein said transgenic plant comprises a transcribable polynucleotide encoding the GAME11 dioxygenase.

23. The genetically modified plant of claim 22 , wherein the transcribable polynucleotide comprises the nucleic acid sequence set forth in any one of SEQ ID NO:9, SEQ ID NO:10, SEQ ID NO:11 and SEQ ID NO:12.

24. The genetically modified plant of claim 1 , wherein said plant is a Solanaceous crop plant having elevated content of at least one steroidal glycoalkaloid selected from the group comprising α-solanine, α-chaconine, solmargine, solasonine, tomatine, tomatidine and derivatives thereof.

25. A method of reducing the content of at least one steroidal alkaloid or a glycosylated derivative thereof in a plant, said method comprising

transforming at least one plant cell with at least one silencing molecule targeted to a nucleic acid sequence encoding at least one protein selected from the group consisting of GAME9-transcription factor and 2-oxoglutarate-dependent dioxygenase (GAME11), or

mutagenizing at least one gene or a combination of genes, said genes encoding at least one protein selected from the group consisting of GAME9-transcription factor and 2-oxyglutarate-dependent dioxygenase (GAME11), wherein said mutagenesis comprises introduction of one or more point mutations into said gene, or genome editing, or use of a bacterial CRISPR/CAS system, or a combination thereof,

wherein the amino acid sequence of the GAME9-transcription factor comprises the sequence set forth in SEQ ID NO:1 or the sequence at least 80% homologous to the sequence set forth in SEQ ID NO: 1, and wherein the amino acid sequence of the 2-oxoglutarate-dependent dioxygenase (GAME11) comprises the sequence set forth in any one of SEQ ID NO:7 and SEQ ID NO:8, thereby producing a plant with reduced content of at least one steroidal alkaloid or a glycosylated derivative thereof compared to a corresponding non-transformed plant.

26. The genetically modified plant of claim 1 , wherein the expression of the at least one gene or any combination thereof is altered, said altering comprising mutagenizing the at least one gene, wherein said mutagenesis comprises introduction of one or more point mutations, or genome editing, or use of a bacterial CRISPR/CAS system, or a combination thereof.

27. The genetically modified plant of claim 7 , wherein said genetically modified plant is a transgenic plant comprising at least one cell comprising at least one transcribable polynucleotide encoding at least one protein selected from the group consisting of GAME9-transcription factor and 2-oxoglutarate-dependent dioxygenase (GAME11), or a combination thereof.

28. The genetically modified plant of claim 27 , wherein said transgenic plant comprises a transcribable polynucleotide encoding the GAME9-transcription factor.

29. The genetically modified plant of claim 28 , wherein the transcribable polynucleotide comprises the nucleic acid sequence set forth in any one of SEQ ID NO:4 and SEQ ID NO:6.

30. The genetically modified plant of claim 27 , wherein said transgenic plant comprises a transcribable polynucleotide encoding the GAME11 dioxygenase.

31. The genetically modified plant of claim 30 , wherein the transcribable polynucleotide comprises the nucleic acid sequence set forth in any one of SEQ ID NO:9, SEQ ID NO:10, SEQ ID NO:11, and SEQ ID NO:12.

32. The genetically modified plant of claim 7 , wherein the expression of the at least one gene or any combination thereof is altered, said altering comprising mutagenizing the at least one gene, wherein said mutagenesis comprises introduction of one or more point mutations, or genome editing, or use of a bacterial CRISPR/CAS system, or a combination thereof.